Developing Costimulatory Molecules for Immunotherapy of Diseases /

Developing Costimulatory Molecules for Immunotherapy of Diseases /

Saved in:

Bibliographic Details
Main Author:	Mir, Manzoor Ahmad (Author)
Format:	Book
Language:	English
Published:	Amsterdam, Boston : Elsevier, c2015.
Online Access:	View in OPAC
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

T Cell Costimulatory Molecules in Anti-Viral Immunity: Potential Role in Immunotherapeutic Vaccines
by: Tania H Watts, et al.
Published: (2003-01-01)

Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis
by: Chenchen Yang, et al.
Published: (2022-01-01)

Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
by: Nien Yee Kow, et al.
Published: (2013-01-01)

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss
by: Tania N. Crotti, et al.
Published: (2015-01-01)

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)

Positive Selection by Purified MHC Class II / Thymic Epithelial Cells In Vitro: Costimulatory Signals Mediated by B7 Are Not Involved
by: Eric J. Jenkinson, et al.
Published: (1994-01-01)

Immunotherapy of Liver Diseases
by: Dechun Feng, et al.
Published: (2019-01-01)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
by: Kouichi Miura, et al.
Published: (2010-01-01)

Synaptic Cell Adhesion Molecules in Alzheimer’s Disease
by: Iryna Leshchyns’ka, et al.
Published: (2016-01-01)

Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?
by: Tom G. Moreels, et al.
Published: (2008-01-01)

Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies
by: Jian Song, et al.
Published: (2019-01-01)

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases
by: Basveshwar Gawali, et al.
Published: (2025-02-01)

Potential and development of cellular vesicle vaccines in cancer immunotherapy
by: Wenxi Zhao, et al.
Published: (2025-01-01)

ATM in immunobiology: From lymphocyte development to cancer immunotherapy
by: Ji-Hoon Lee
Published: (2025-02-01)

Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
by: Naofumi Mukaida, et al.
Published: (2014-01-01)

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
by: Yuehong Chen, et al.
Published: (2019-01-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Development status of electrocatalytic hydrogenation of biomass small molecules and prospects for industrial production
by: Yuchen Lei, et al.
Published: (2025-02-01)

L-Ascorbic Acid: A Multifunctional Molecule Supporting Plant Growth and Development
by: Daniel R. Gallie
Published: (2013-01-01)

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections
by: Fabio Morandi, et al.
Published: (2014-01-01)

Microbial molecules, metabolites, and malignancy
by: Ryan M. Thomas
Published: (2025-02-01)

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
by: A. E. Albers, et al.
Published: (2010-01-01)

Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01)

Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease
by: Benoît Leclerc, et al.
Published: (2013-01-01)

Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules
by: João Victor Marcelino de Souza, et al.
Published: (2025-01-01)

Gastroenterological Cancer and Immunotherapy
by: Xiaoping Wang, et al.
Published: (2018-01-01)

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016
by: Roberta Rizzo, et al.
Published: (2017-01-01)

Tritonlike Molecules of Three Identical Baryons
by: Li Ma
Published: (2022-01-01)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
by: Magali Terme, et al.
Published: (2012-01-01)

Leukocyte Adhesion Molecules in Diabetic Retinopathy
by: Kousuke Noda, et al.
Published: (2012-01-01)

Single-Molecule Analysis of Alkaline Phosphatase
by: Douglas B. Craig
Published: (2024-10-01)

SU(N) magnetism with ultracold molecules
by: Bijit Mukherjee, et al.
Published: (2025-01-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Urinary vascular cell adhesion molecule-1 as a marker of disease activity in lupus nephritis
by: Shivraj Padiyar, et al.
Published: (2021-01-01)

Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept Study
by: Liam M. Ashander, et al.
Published: (2016-01-01)

Cancer Immunotherapy: Theory and Application
by: Guobing Chen, et al.
Published: (2018-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
by: Jie Ma, et al.
Published: (2025-01-01)

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients
by: Amalia Azzariti, et al.
Published: (2025-02-01)